Working… Menu

Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI (IMPLANT2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03081208
Recruitment Status : Completed
First Posted : March 16, 2017
Last Update Posted : December 23, 2019
Information provided by (Responsible Party):
ObsEva SA